T he cardiovascular disease (CVD) risk associated with diabetes mellitus (DM) has become increasingly evident, accounting for 80% of deaths among patients with this disease 1 and making CVD risk modification a key therapeutic objective in diabetic patients. 2]
No takes yet. Share an insight, caveat, or question.
McGuire et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: